Talpha1, Zadaxin, thymalfasin · Evidence-based safety and harm-reduction overview.
| Also known as | Talpha1, Zadaxin, thymalfasin |
| Category | Peptide |
| approval_regions | Approved as Zadaxin in Italy, France, some Asian countries; not FDA-approved in US |
| mechanism_class | Immunomodulatory peptide |
| route | Subcutaneous or intramuscular injection |
| peptide_origin | Derived from prothymosin alpha; thymus-derived but synthetically produced |
| US legal status | Thymosin alpha-1 (thymalfasin) is approved and marketed as Zadaxin in some countries including Italy, China, and others for certain conditions such as chronic hepatitis B, but it is not FDA-approved in the United States for general use. In the US it is sold mainly as a research chemical or through compounding under restrictions, and is not a lawful over-the-counter product. |
Thymosin alpha-1 is a 28-amino-acid peptide fragment derived from prothymosin alpha, a molecule originally identified and extracted from the thymus gland. It is thought to help modulate and enhance T-cell and immune-cell activity rather than act as a direct antimicrobial or hormone replacement.
Thymosin alpha-1 is thought to activate and differentiate T-lymphocytes, particularly by enhancing interleukin-2 (IL-2) production and supporting T-helper (Th1) responses. It may also enhance natural killer cell function and dendritic cell maturation, though the precise molecular receptors and pathways in human immune cells remain incompletely understood.
Thymosin alpha-1 was first isolated and characterized from calf thymus tissue in the 1970s. It was developed as a therapeutic agent in Italy and subsequently approved in several countries for hepatitis B and immune support. It has remained popular in European and Asian alternative medicine but was never successful in US FDA clinical development.
Research suggests thymosin alpha-1 can modulate T-cell function, enhance T-helper responses, and boost natural killer cell activity in laboratory and ex-vivo settings. It has clinical-trial and regulatory approval support in some countries as an adjunct in chronic hepatitis B, and has been investigated in cancer, vaccination, and infectious-disease settings with mixed and often modest results. High-quality, US-recognized evidence for general 'immune-boosting' use in healthy people is limited and does not support broad therapeutic claims.
In clinical trials conducted outside the US, thymosin alpha-1 was typically studied at doses of 1.6 mg intramuscularly or subcutaneously, often given three times per week; however, dosing in gray-market use varies widely and is not standardized or validated.
This is general research/context information, not medical advice or a recommended protocol.
Combining thymosin alpha-1 with other immunomodulating peptides or botanicals (like echinacea or astragalus) in uncontrolled settings is not studied and creates unpredictable immune responses.
If you are going to research a compound, verifying identity and purity is the single most protective step. Independent analytical testing and sterile-handling supplies reduce risk.
Compare testing optionsNo, it is not FDA-approved for general use in the United States, though it is approved and marketed as Zadaxin in some other countries for specific conditions such as chronic hepatitis B and certain immune deficiencies.
Research suggests it can modulate immune cell activity in specific clinical settings, but evidence for general immune-boosting in healthy people is limited. Modulating immune function can be risky, especially for people with autoimmune conditions, so it is not a casual supplement.
No. Thymosin alpha-1 is a specific, purified peptide, whereas thymic extract is a crude animal-derived mixture. Thymosin alpha-1 is more defined but still not FDA-approved in the US.
No. Immunomodulators can worsen or trigger autoimmune flares. Do not use without explicit approval from a specialist managing your condition.
Medical & legal disclaimer. This site is for informational and harm-reduction purposes only. It is not medical advice and is not a substitute for a licensed healthcare professional. The compounds discussed are largely not approved by the FDA for human use and many are sold strictly as research chemicals 'not for human consumption.' Nothing here is an endorsement to purchase, possess, or use any substance. Laws vary by jurisdiction. Always consult a qualified physician and follow the law where you live.
Some links on this page may be affiliate links. If you buy through them we may earn a commission at no extra cost to you. This never changes the safety information we publish.